S 8510
Alternative Names: 737552; SB 737552Latest Information Update: 22 Feb 2005
At a glance
- Originator Shionogi
- Developer Shionogi; Shionogi-GlaxoSmithKline Pharmaceuticals LLC
- Class Antidepressants; Benzodiazepines; Neuroprotectants; Nootropics
- Mechanism of Action GABA A receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Dementia
Most Recent Events
- 31 Jan 2005 Discontinued - Phase-I for Alzheimer's disease in Europe (PO)
- 31 Jan 2005 Discontinued - Phase-I for Dementia in Europe (PO)
- 31 Jan 2005 Discontinued - Phase-II for Alzheimer's disease in Japan (PO)